文献

J-GLOBAL ID：202202290092327832   整理番号：22A1143790

日本のCOVID-19患者の間でのCOVID-19重症肺炎の予防におけるmRNAワクチンの効果

Effect of mRNA Vaccines in Preventing COVID-19 Severe Pneumonia Among COVID-19 Patients in Japan

著者 (6件)： Matsuo Rumi (Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University) ,  Matsumoto Naomi (Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University) ,  Kadowaki Tomoka (Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University) ,  Mitsuhashi Toshiharu (Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University) ,  Takao Soshi (Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University) ,  Yorifuji Takashi (Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University)
資料名： Journal of Epidemiology (Web)  (Journal of Epidemiology (Web))
巻： 32  号： 3  ページ： 151-152(J-STAGE)  発行年： 2022年 
JST資料番号： U0710A  ISSN： 1349-9092  資料種別： 逐次刊行物 (A)
記事区分： 短報  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： ・COVID-19に対するmRNAワクチン有効性の研究は主に...

シソーラス用語： ヒト ,...
準シソーラス用語： *COVID-19 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=22A1143790&from=J-GLOBAL&jstjournalNo=U0710A") }}

分類 (3件)： 感染症・寄生虫症一般  (GD01010H) ,  呼吸器の疾患  (GI03000Z) ,  免疫療法薬・血液製剤の臨床への応用  (GW22020O)

引用文献 (6件)：

• 1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. C4591001 Clinical Trial Group. N Engl J Med. 2020;383:2603-2615.
• 2. Okayama Prefecture. L452R mutant test results. https://www.pref.okayama.jp/page/724270.html#00-452henikabu-pcr; 2021 Accessed October 16 2021.
• 3. Ministry of Health, Labour and Welfare in Japan. Clinical management of Patients with COVID-19 (version 5.3). https://www.mhlw.go.jp/content/000829136.pdf; 2021 Accessed December 10 2021.
• 4. Terada M, Ohtsu H, Saito S, et al. Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan. BMJ Open. 2021;11:e047007.
• 5. Young-Xu Y, Korves C, Roberts J, et al. Coverage and estimated effectiveness of mRNA COVID-19 vaccines among US veterans. JAMA Netw Open. 2021;4:e2128391.

タイトルに関連する用語 (6件)： 日本 ,  COVID-19 ,  患者 ,  重症肺炎 ,  予防 ,  mRNAワクチン